Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Millennium Biotechnologies was a biopharmaceutical company that specialized in the development and commercialization of medical foods and nutritional supplements for patients with chronic and wasting diseases. The company's primary focus was its flagship product, Resurgere, a patented nutritional formula designed to provide immune support for individuals suffering from HIV/AIDS, cancer, and hepatitis. Millennium sought to bridge the gap between traditional clinical nutrition and pharmaceutical therapy by utilizing evidence-based formulations to combat cachexia and improve patient quality of life. Although the company was publicly traded on the OTC market, it has since ceased active operations and is considered defunct.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Millennium Biotechnologies.